Senate BillChaptered/SignedHealth and Safety
SB 1306: Controlled substances: gamma-butyrolactone.
What SB 1306 does, verified September 29, 2026
The bill would exempt certain chemical mixtures containing gamma-butyrolactone (GBL) from specific requirements related to controlled substances. It would allow the sale, transfer, or other furnishing of these mixtures to persons or entities in California or other states without obtaining a permit from the Department of Justice. The exemption would apply to mixtures that contain GBL and were obtained or received from a source within or outside the state or were obtained, received, sold, transferred, or exported to any state. This exemption would not apply to requirements related to the sale of chemical reagents or solvents with a value over $100, unless the presence of GBL is solely due to the mixture.
Bill journey
✓IntroducedComplete
✓In CommitteeComplete
✓First Chamber FloorComplete
✓Second ChamberComplete
✓GovernorComplete
6ChapteredCurrent
Last action: Chaptered by Secretary of State. Chapter 694, Statutes of 2026. (2026-09-27)Alert me
Author and sponsors
Full contact details, staff, and committees with Connect, $16/moUnlockRecent actions21 total · showing 5
| Sep. 27, 2026 | Chaptered by Secretary of State. Chapter 694, Statutes of 2026. |
| Sep. 27, 2026 | Approved by the Governor. |
| Aug. 21, 2026 | Enrolled and presented to the Governor at 3 p.m. |
| Aug. 18, 2026 | In Senate. Ordered to engrossing and enrolling. |
| Aug. 17, 2026 | Read third time. Passed. (Ayes 45. Noes 5. Page 6210.) Ordered to the Senate. |
Latest bill textChaptered version, September 27, 2026 · 867 words
Senate Bill No. 1306
CHAPTER 694
An act to add Section 11112 to the Health and Safety Code, relating to controlled substances.
[ Approved by Governor September 27, 2026. Filed with Secretary of State September 27, 2026. ]
LEGISLATIVE COUNSEL'S DIGEST
SB 1306, Cortese. Controlled substances: gamma-butyrolactone.
Existing law requires any manufacturer, wholesaler, retailer, or other person in this state who sells, transfers, or otherwise furnishes any of a list of specified chemical substances, including gamma-butyrolactone (GBL), to take specified actions, including to apply to and obtain a permit from the Department of Justice in order to sell, transfer, or otherwise furnish the substances specified above and to submit specified reports to the department, including if the entity obtains any of the substances specified above from a source outside of this state or if a permittee described above discovers the theft or loss of any of the substances specified above. Existing law makes failure to submit a report described above, and selling, transferring, or otherwise furnishing or obtaining any of the specified substances without a permit, a misdemeanor or a felony.
This bill would exempt specified chemical mixtures that contain GBL that are obtained or received from a source within or outside this state or are obtained, received, sold, transferred, exported, or otherwise furnished to any person or entity in this state or any other state from the requirements described above.
Existing law requires any manufacturer, wholesaler, retailer, or other person that sells to any person or entity in this state or any other state, any chemical reagent or solvent of a value greater than $100 to take specified actions, including to prepare and sign a bill of sale with specified information and to retain the bill of sale for a specified period of time. Existing law makes a violation of this requirement a misdemeanor.
This bill would exempt specified chemical mixtures that contain GBL that are obtained or received from a source within or outside this state or are obtained, received, sold, transferred, exported, or otherwise furnished to any person or entity in this state or any other state from the requirements described above if the requirements would be imposed solely due to the presence of GBL in the mixtures.
This bill would make related findings and declarations.
The people of the State of California do enact as follows:
SECTION 1.
The Legislature finds and declares all of the following:(a) Semiconductors are foundational to California’s economy, national security, and technological leadership, and are essential to the communications, transportation, health care, energy, and defense industries.
(b) California stands at the forefront of semiconductor research and design. However, retaining and expanding in-state semiconductor manufacturing is critical to supply chains and economic competitiveness.
(c) Semiconductor fabrication facilities rely on highly specialized industrial chemicals and solvents, including gamma-butyrolactone (GBL).
(d) In 2010, the United States Drug Enforcement Administration (DEA), through promulgation of Section 1310.12 of Title 21 of the Code of Federal Regulations, designated chemical mixtures containing GBL as exempt from specified regulatory requirements of the federal Controlled Substances Act if they have a concentration equal or less than 70 percent by weight or volume. In the rulemaking, the DEA identified the 70 percent concentration limit as an appropriate level that did not pose a significant risk of diversion to traffickers for illicit purposes.
(e) California law has not been updated to reflect these federal exemptions. Existing state law, Section 11100 of the Health and Safety Code, includes GBL at any concentration level on the list of controlled precursor chemicals subject to reporting and regulatory requirements.
(f) This misalignment imposes unnecessary compliance burdens on semiconductor manufacturers in California, including permitting, reporting, and enforcement requirements that are unrelated to public safety outcomes and that do not apply in other leading semiconductor manufacturing states.
(g) Florida and New Jersey are significantly less restrictive in regards to regulation of GBL because their statutes exempt industrial uses, while others, including Arizona and Texas, impose fewer barriers in practice by deferring to federal standards. California remains comparatively more restrictive for advanced manufacturing.
SEC. 2.
Section 11112 is added to the Health and Safety Code, to read:11112.
(a) Sections 11100, 11100.1, 11103, and 11106 do not apply to chemical mixtures containing gamma-butyrolactone that are obtained or received from a source within or outside this state or are sold, transferred, exported, or otherwise furnished to any person or entity in this state or any other state.(b) Section 11107 does not apply to the mixtures described in subdivision (a) if the requirements would be imposed solely due to the presence of gamma-butyrolactone in the mixtures.
(c) For the purposes of this section, the following terms have the following meanings:
(1) “Chemical mixtures containing gamma-butyrolactone” means two or more chemical substances, one of which is gamma-butyrolactone (CAS no. 96-48-0) in a concentration of 70 percent or less by weight or volume, and at least one other substance that is not solely an inert carrier or an impurity.
(2) “Inert carrier” means a chemical that does not interfere with the function of gamma-butyrolactone (CAS no. 96-48-0) in the mixture but is present to aid in its delivery so it can be used in a chemical process.
Text of SB 1306 as chaptered, from the official record. Connect Plus keeps every version and highlights what changed.Compare versions